1604 Belimumab与口服免疫抑制剂在非肾系统性红斑狼疮患者中感染的风险比较

{"title":"1604 Belimumab与口服免疫抑制剂在非肾系统性红斑狼疮患者中感染的风险比较","authors":"A. Jorge, E. Materne, Hyon-Min Choi, Baijun Zhou, K. Costenbader, Yuqing Zhang","doi":"10.1136/lupus-2022-lupus21century.99","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":74431,"journal":{"name":"Pharmacoepidemiology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"1604 Comparative Risks of Infection with Belimumab versus Oral Immunosuppressants in Patients with Non-Renal Systemic Lupus Erythematosus\",\"authors\":\"A. Jorge, E. Materne, Hyon-Min Choi, Baijun Zhou, K. Costenbader, Yuqing Zhang\",\"doi\":\"10.1136/lupus-2022-lupus21century.99\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":74431,\"journal\":{\"name\":\"Pharmacoepidemiology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmacoepidemiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/lupus-2022-lupus21century.99\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacoepidemiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/lupus-2022-lupus21century.99","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}